1986
DOI: 10.1111/j.1365-4362.1986.tb04705.x
|View full text |Cite
|
Sign up to set email alerts
|

Proximal White Subungual Onychomycosis in a Patient with Acquired Immune Deficiency Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
14
0
1

Year Published

1989
1989
2018
2018

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(16 citation statements)
references
References 3 publications
1
14
0
1
Order By: Relevance
“…10 Therefore, the presence of onychomycosis, in particular proximal white superficial onychomycosis, may be a visible marker of the degree of immunodeficiency. 26–31 Proximal subungual onychomycosis has rarely been reported in other populations 32,33 . 34,35 …”
Section: Introductionmentioning
confidence: 99%
“…10 Therefore, the presence of onychomycosis, in particular proximal white superficial onychomycosis, may be a visible marker of the degree of immunodeficiency. 26–31 Proximal subungual onychomycosis has rarely been reported in other populations 32,33 . 34,35 …”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5][6] It is now established that tinea pedis and onychomycosis are more frequent in HIVinfected patients, 7,8 who can present with uncommon proximal or superficial onychomycosis. 9,10 Another well-known ungual symptom is the presence of longitudinal melanonychia associated or not with treatment by zidovudine. [11][12][13][14][15] Rare cases of yellow nail syndrome were described in association with the acquired immunodeficiency syndrome (AIDS).…”
mentioning
confidence: 99%
“…In a report of patients from Canada and Brazil, WSO had prevalence of 3.3% and 5% and for PWSO of 1.5% and 3% respectively. The overall prevalence for onychomycosis in HIV infected patients was reported of 23.2% Cribier et al, 1998;Dompmartin et al, 1990;Gupta et al 2000;Noppakun & Head, 1986;Weismann et al 1988). Among patients living with HIV/AIDS, onychomycosis is the fourth most common dermatological manifestation, with an incidence of 10-44%, and an estimated prevalence 15-40%.…”
Section: Epidemiologymentioning
confidence: 99%